Pursuant to the provisions of Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you ....
ELITECON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Elitecon International's board, meeting on August 12, 2025, approved unaudited standalone and consolidated results for Q1 FY26 (quarter ended June 30, 2025). On a consolidated basis, total income jumped to Rs. 52,487.39 lakhs (vs Rs. 31,388.79 lakhs in Q4 FY25) and net profit rose to Rs. 7,208.25 lakhs (vs Rs. 4,297.31 lakhs in Q4 FY25). Standalone revenue surged to Rs. 19,929.35 lakhs from Rs. 4,956.06 lakhs a year ago, with PAT at Rs. 2,040.54 lakhs vs Rs. 453.59 lakhs. The growth was driven by a new Agro Products segment (Rs. 19,877.65 lakhs) and stronger Tobacco revenue (Rs. 32,609.66 lakhs). The board also approved incorporating a wholly owned subsidiary in Indonesia and noted the recently completed 10:1 stock split (face value Rs. 10 to Rs. 1). Key concerns flagged in auditor's review: a GST Show Cause Notice of Rs. 387.43 crores from DGGI (covering Oct 2020–Oct 2024) is pending adjudication, plus four additional SCNs worth Rs. 22.23 crores related to CGST refunds — together representing a very large contingent liability. A Rs. 575.45 lakh loss on disposal of old plant & machinery at subsidiary Golden Cryo was also booked.
Sharp revenue and profit growth, partly fuelled by a new subsidiary, looks positive on the surface, but the Rs. 387+ crore GST notice is a serious overhang that could materially impact future earnings if ruled against the company. The Indonesia subsidiary and stock split signal expansion ambitions, but investors should weigh the strong growth story against the large unresolved tax exposure.